SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236030-24-000015
Filing Date
2024-05-10
Accepted
2024-05-10 09:04:18
Documents
1
Period of Report
2024-05-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3260
  Complete submission text file 0001236030-24-000015.txt   4819
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Issuer) CIK: 0000725363 (see all company filings)

IRS No.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 245 N. HIGHLAND AVE NE SUITE 230-296 ATLANTA GA 30307
Business Address
Watson Robert Eugene (Reporting) CIK: 0001511858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-11889 | Film No.: 24933047